dc.contributor.author
Steinbrenner, Mirja
dc.contributor.author
Duncan, John S.
dc.contributor.author
Dickson, John
dc.contributor.author
Rathore, Chaturbhuj
dc.contributor.author
Wächter, Bettina
dc.contributor.author
Aygun, Nafi
dc.contributor.author
Menon, Ramshekhar N.
dc.contributor.author
Radhakrishnan, Ashalatha
dc.contributor.author
Holtkamp, Martin
dc.contributor.author
Ilyas‐Feldmann, Maria
dc.date.accessioned
2025-04-08T13:39:58Z
dc.date.available
2025-04-08T13:39:58Z
dc.identifier.uri
https://refubium.fu-berlin.de/handle/fub188/47217
dc.identifier.uri
http://dx.doi.org/10.17169/refubium-46935
dc.description.abstract
Objective
18F-Fluorodeoxyglucose positron emission tomography (FDG-PET) is widely used in presurgical assessment in patients with drug-resistant focal epilepsy (DRE) if magnetic resonance imaging (MRI) and scalp electroencephalography (EEG) do not localize the seizure onset zone or are discordant.
Methods
In this multicenter, retrospective observational cohort study, we included consecutive patients with DRE who had undergone FDG-PET as part of their presurgical workup. We assessed the utility of FDG-PET, which was defined as contributing to the decision-making process to refer for resection or intracranial EEG (iEEG) or to conclude surgery was not feasible.
Results
We included 951 patients in this study; 479 had temporal lobe epilepsy (TLE), 219 extratemporal epilepsy (ETLE), and 253 epilepsy of uncertain lobar origin. FDG-PET showed a distinct hypometabolism in 62% and was concordant with ictal EEG in 74% in TLE and in 56% in ETLE (p < .001). FDG-PET was useful in presurgical decision-making in 396 patients (47%) and most beneficial in TLE compared to ETLE (58% vs. 44%, p = .001). Overall, FDG-PET contributed to recommending resection in 78 cases (20%) and iEEG in 187 cases (47%); in 131 patients (33%), FDG-PET resulted in a conclusion that resection was not feasible. In TLE, seizure-freedom 1 year after surgery did not differ significantly (p = .48) between patients with negative MRI and EEG-PET concordance (n = 30, 65%) and those with positive MRI and concordant EEG (n = 46, 68%). In ETLE, half of patients with negative MRI and EEG-PET concordance and three quarters with positive MRI and concordant EEG were seizure-free postsurgery (n = 5 vs. n = 6, p = .28).
Significance
This is the largest reported cohort of patients with DRE who received presurgical FDG-PET, showing that FDG-PET is a useful diagnostic tool. MRI-negative and MRI-positive cases with concordant FDG-PET results (with either EEG or MRI) had a comparable outcome after surgery. These findings confirm the significance of FDG-PET in presurgical epilepsy diagnostics.
en
dc.rights.uri
https://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subject
drug-resistant epilepsy
en
dc.subject
epilepsy surgery
en
dc.subject
18F-fluorodeoxyglucose PET
en
dc.subject
presurgical assessment
en
dc.subject.ddc
600 Technik, Medizin, angewandte Wissenschaften::610 Medizin und Gesundheit::610 Medizin und Gesundheit
dc.title
Utility of 18F‐fluorodeoxyglucose positron emission tomography in presurgical evaluation of patients with epilepsy: A multicenter study
dc.type
Wissenschaftlicher Artikel
dcterms.bibliographicCitation.doi
10.1111/epi.17194
dcterms.bibliographicCitation.journaltitle
Epilepsia
dcterms.bibliographicCitation.number
5
dcterms.bibliographicCitation.originalpublishername
Wiley
dcterms.bibliographicCitation.pagestart
1238
dcterms.bibliographicCitation.pageend
1252
dcterms.bibliographicCitation.volume
63
refubium.affiliation
Charité - Universitätsmedizin Berlin
refubium.funding
DEAL Wiley
refubium.resourceType.isindependentpub
no
dcterms.accessRights.openaire
open access
dcterms.bibliographicCitation.pmid
35166379
dcterms.isPartOf.issn
0013-9580
dcterms.isPartOf.eissn
1528-1167